The US Food & Drug Administration is facing a most unusual leadership transition with Acting Commissioner Janet Woodcock seemingly undergoing an informal tryout period that could end with her becoming the first career FDA official to be made commissioner since before the Nixon Administration.
US FDA’s Big Transition: Not The Commissioner – The Drug Center
It remains uncertain whether Acting Commissioner Woodcock will be nominated for the post. Regardless, the drug center she has run for most of three decades is going to have to adjust to new management.
